Pricing Log in Create free account

Aurinia Pharmaceuticals Inc (AUPH) vs Harmony Biosciences Holdings, Inc. (HRMY)

Aurinia Pharmaceuticals Inc and Harmony Biosciences Holdings, Inc. are both Biotechnology companies. Aurinia Pharmaceuticals Inc and Harmony Biosciences Holdings, Inc. are of similar size ($2.2B and $2.2B). Aurinia Pharmaceuticals Inc trades at the lower P/E: 6.9× against 12.2×. Harmony Biosciences Holdings, Inc. grew revenue faster over the last twelve months: 24.3% against 19.8%. Aurinia Pharmaceuticals Inc has the higher net margin (100.8% vs 18.9%) and the higher return on invested capital (40.8% vs 29.7%). Across the 21 metrics below, Aurinia Pharmaceuticals Inc leads on 13 and Harmony Biosciences Holdings, Inc. on 8.

Valuation

Metric AUPH HRMY Biotechnology median
P/E 6.91 12.20 8.50
P/S 6.89 2.31 9.71
P/B 3.49 2.21 2.13
Price to free cash flow 12.27 7.03 20.82
EV/EBITDA 10.93 6.65 0.64
EV/Sales 5.61 1.77 9.21
Earnings yield 14.48% 8.19% (33.15%)
Free cash flow yield 8.15% 14.22% (25.50%)

Profitability

Metric AUPH HRMY Biotechnology median
Gross margin 90.36% 75.42% 65.16%
Operating margin 45.15% 24.03% 0.00%
Net margin 100.84% 18.88% 0.00%
Free cash flow margin 56.20% 36.99% 0.00%
Return on equity 66.12% 20.46% (56.36%)
Return on assets 48.52% 14.61% (48.04%)
Return on invested capital 40.76% 29.70% 0.00%

Growth

Metric AUPH HRMY Biotechnology median
Revenue growth (TTM) 19.76% 24.25% 6.02%
EPS growth (last fiscal year) 5,075.00% 7.97% 30.26%
Revenue growth, 5-year CAGR 41.38% 40.30% 9.41%
Net income growth, 5-year CAGR 0.00% 0.00% 0.00%

Health

Metric AUPH HRMY Biotechnology median
Debt to equity 0.07 0.15 0.00
Current ratio 5.42 3.48 4.72
Net debt to EBITDA (2.58) (2.63) 0.96

Dividend

Metric AUPH HRMY Biotechnology median
Dividend yield — — 0.09%
Payout ratio — — —

Size

Metric AUPH HRMY Biotechnology median
Market cap 2.23b 2.23b 135.18m

Compare with another peer

Any metric, up to five companies and an Excel export Powerpack